This news release contains forward-looking statements about continued collaboration with corporate partner, future product development, clinical trials and financial results. These statements represent our judgment as the date of this news release and are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed in such forward-looking statements. In particular, we face risks and uncertainties that product development may not succeed, that clinical trials may not go forward as planned, or may not succeed, that our cash burn rate will exceed our projections and that the value of our marketable securities may be affected by fluctuations in the stock market. These documents contain and identify important factors that could cause the actual results to differ materially from those contained in the forward-looking statements. The Scleroderma Foundation in no way endorses any drugs or treatments reported on this website.
Information is provided as a resource to be used with discretion.
Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with one's physician to assure proper evaluation and treatment.